Gerresheimer AG (ETR:GXI – Get Free Report)’s stock price reached a new 52-week low during trading on Tuesday . The company traded as low as €74.50 ($78.42) and last traded at €75.20 ($79.16), with a volume of 151610 shares traded. The stock had previously closed at €73.85 ($77.74).
Gerresheimer Stock Performance
The company has a quick ratio of 0.40, a current ratio of 0.87 and a debt-to-equity ratio of 79.36. The stock has a market cap of $2.60 billion, a P/E ratio of 22.59, a price-to-earnings-growth ratio of 0.82 and a beta of 0.94. The firm’s 50-day moving average is €83.14 and its two-hundred day moving average is €94.16.
About Gerresheimer
Gerresheimer AG, together with its subsidiaries, manufactures and sells medicine packaging, drug delivery devices, and solutions in Germany and internationally. It operates through three divisions: Plastics & Devices, Primary Packaging Glass, and Advanced Technologies. The company offers prefillable syringes, plastic and glass packaging solutions, vials, glass cartridges and ampoules, bottles and containers, and glass bottles and jars, as well as caps, closures, applicators, and accessories; development, industrialization and contract manufacturing of drug delivery programs; project and quality management; and drug delivery systems, including inhalers, injection/auto injectors, pen injectors, infusion systems, and inhalation assessment, autoinjector, and other services.
Read More
- Five stocks we like better than Gerresheimer
- Procter & Gamble (NYSE:PG) Pulls Back After Shaky Guidance
- Cerence Up 155% in 2 Days: SoundHound AI’s Fierce Competitor
- Do ETFs Pay Dividends? What You Need to Know
- Why Warren Buffett Is Selling: A Look at His Latest Market Moves
- Learn Technical Analysis Skills to Master the Stock Market
- Why Amazon Shares May Never Trade Below $200 Again
Receive News & Ratings for Gerresheimer Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Gerresheimer and related companies with MarketBeat.com's FREE daily email newsletter.